Search Bar & Filters
Found 2 Actively Recruiting clinical trials
Actively Recruiting
Healthy Volunteer
Researchers are studying how the immune system responds to viruses that can pass from animals to humans, focusing on healthy adults aged 18 to 65 years in Cambodia. The study aims to understand immunity to specific zoonotic viruses such as H5N1, Nipah virus, and bat coronaviruses by recruiting people with high-risk exposure to animals or their waste, or who live near animal habitats like bat caves or markets. This observational research is conducted by Cambodian and NIH scientists to gather important immune data without direct intervention. Participants provide blood samples to help identify immune responses to these viruses. The main procedure involves collecting 30 mL of whole blood at the start of the study, with up to two optional additional collections at least 30 days apart, between six months and two years after enrollment. The study focuses on analyzing antibodies and immune cells that react to viral proteins at various time points. During the study, participants will have blood drawn and may attend up to three visits over a period ranging from 180 to 720 days. Researchers will measure antibody activity and isolate specific immune cells from plasma samples to better understand immune signatures. The study monitors participant health and stores samples and data for future research, all while ensuring voluntary participation and informed consent throughout the process.
Actively Recruiting
Healthy Volunteer
Vector-borne diseases, caused by bites from infected insects like mosquitoes and ticks, are a major health concern worldwide, causing nearly 1 million deaths annually. These illnesses are increasing, especially in Southeast Asia, with about 10 percent of fevers in Cambodia linked to such infections. Many cases go undiagnosed due to limited diagnostic resources, so researchers aim to better understand these diseases and identify infectious causes of unexplained fevers using advanced genetic sequencing methods. Participants include individuals aged at least 2 months who have a fever of 38 degrees Celsius or higher, or who are diagnosed with certain high-risk pathogens. Close contacts of infected individuals may also join the study. Participants provide information about their health, travel history, and demographics. Blood samples and nasal swabs if respiratory symptoms are present are collected for testing. Optional follow-up samples may be collected within 1 to 2 weeks andor up to 3 months after enrollment. During the study, participants answer health questionnaires and undergo blood and nasal testing to detect pathogens and immune responses. Researchers analyze pathogen genetic sequences and assess reactions to insect saliva proteins. The study includes initial enrollment and optional follow-up visits to track infections and immune changes over time. Total participation duration varies depending on follow-up involvement.